Lexchin J - Search Results

1

Why do cancer drugs get such an easy ride?

Light DW, Lexchin J. Light DW, et al. Among authors: lexchin j. BMJ. 2015 Apr 23;350:h2068. doi: 10.1136/bmj.h2068. BMJ. 2015. PMID: 25908437 No abstract available.

2

Code of marketing practices. Voluntary self-regulation for the Pharmaceutical Manufacturers Association of Canada.

Lexchin J. Lexchin J. Can Fam Physician. 1997 Nov;43:1997. Can Fam Physician. 1997. PMID: 9386886 Free PMC article. No abstract available.

3

After compulsory licensing: coming issues in Canadian pharmaceutical policy and politics.

Lexchin J. Lexchin J. Health Policy. 1997 Apr;40(1):69-80. doi: 10.1016/s0168-8510(96)00886-x. Health Policy. 1997. PMID: 10165902

4

Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey.

Mintzes B, Barer ML, Kravitz RL, Kazanjian A, Bassett K, Lexchin J, Evans RG, Pan R, Marion SA. Mintzes B, et al. Among authors: lexchin j. BMJ. 2002 Feb 2;324(7332):278-9. doi: 10.1136/bmj.324.7332.278. BMJ. 2002. PMID: 11823361 Free PMC article. No abstract available.

5

Pharmaceutical industry sponsorship and research outcome and quality: systematic review.

Lexchin J, Bero LA, Djulbegovic B, Clark O. Lexchin J, et al. BMJ. 2003 May 31;326(7400):1167-70. doi: 10.1136/bmj.326.7400.1167. BMJ. 2003. PMID: 12775614 Free PMC article. Review.

6

Transparency in drug regulation: mirage or oasis?

Lexchin J, Mintzes B. Lexchin J, et al. CMAJ. 2004 Nov 23;171(11):1363-5. doi: 10.1503/cmaj.1041446. CMAJ. 2004. PMID: 15557590 Free PMC article. No abstract available.

7

Implications of pharmaceutical industry funding on clinical research.

Lexchin JR. Lexchin JR. Ann Pharmacother. 2005 Jan;39(1):194-7. doi: 10.1345/aph.1E224. Epub 2004 Nov 23. Ann Pharmacother. 2005. PMID: 15562137

8

Intellectual property rights and the Canadian pharmaceutical marketplace: where do we go from here?

Lexchin J. Lexchin J. Int J Health Serv. 2005;35(2):237-56. doi: 10.2190/Y8UR-YWVR-BUDP-CDR0. Int J Health Serv. 2005. PMID: 15932005

9

Foreign free riders and the high price of US medicines.

Light DW, Lexchin J. Light DW, et al. Among authors: lexchin j. BMJ. 2005 Oct 22;331(7522):958-60. doi: 10.1136/bmj.331.7522.958. BMJ. 2005. PMID: 16239695 Free PMC article. Review.

10

A comparison of new drug availability in Canada and the United States and potential therapeutic implications of differences.

Lexchin J. Lexchin J. Health Policy. 2006 Dec;79(2-3):214-20. doi: 10.1016/j.healthpol.2005.12.015. Epub 2006 Feb 10. Health Policy. 2006. PMID: 16472888

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results